GlassScriptPhysician profile
Stephanie Sammons
NPI 1598026163
$2,630.71
in general payments reported to CMS, 2019-2025
17 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $21.15 · 2021: $17.24 · 2022: $35.83 · 2023: $13.98 · 2024: $2,130 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $696 · Travel and Lodging: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $696.04 |
| Travel and Lodging | $228.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,202.46 | 2024-2025 | |
| Abbvie INC. | $120.99 | 2019-2022 | |
| Hologic Sales and Service, LLC | $34.32 | 2024 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Ethicon US, LLC | $31.99 | 2024 | Ethicon |
| Biogen, INC. | $29.25 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $27.16 | 2019-2022 | |
| Astellas Pharma US INC | $23.56 | 2025 | Veozah |
| Vertex Pharmaceuticals Incorporated | $22.70 | 2025 | |
| Medtronic, INC. | $20.12 | 2024 | Truclear |
| Sumitomo Pharma America, INC. | $17.88 | 2025 | Myfembree |
| Medicem INC. | $17.24 | 2021 | |
| Exeltis, USA INC. | $15.27 | 2025 | Slynd |
| Roche Diagnostics Corporation | $15.14 | 2019 | |
| Organon LLC | $13.98 | 2023 | Nexplanon |
| Boston Scientific Corporation | $13.86 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $13.49 | 2025 | Femlyv |
| Covidien LP | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Sammons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.